Novo Nordisk | NVO - Stock


Novo Nordisk reported DKK42.85B in Stock for its fiscal quarter ending in March of 2025.





Stock Change Date
ANI Pharmaceuticals USD 143.47M 401K Mar/2026
Aurora Cannabis CAD 230.56M 8.6M Dec/2025
Bausch Health Companies USD 1.63B 31M Dec/2025
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Canopy Growth CAD 105.56M 3.18M Dec/2025
Corcept Therapeutics USD 12.89M 22K Mar/2026
Drreddys Laboratories INR 79.01B 3.41B Dec/2025
Eli Lilly USD 14.53B 785M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Merck USD 6.48B 179M Mar/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.29B 17M Mar/2026
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Novo Nordisk DKK 42.85B 2B Mar/2025
Pacira USD 150.37M 2.49M Mar/2026
Perrigo USD 1.12B 27.6M Mar/2026
Phibro Animal Health USD 539.7M 22.35M Mar/2026
Prestige Brands USD 163.59M 4.6M Dec/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Supernus Pharmaceuticals USD 110.77M 1.71M Mar/2026
Zoetis USD 2.55B 120M Mar/2026